Correvio Pharma Corp. Long-Term Debt, Maturity, Year Three
Correvio Pharma Corp. had Long-Term Debt, Maturity, Year Three of $8.70 million as of 2019-12-31, per its 20-F filed 2020-04-30.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Two and Three
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree · last filed 2020-04-30
- 2019-12-31: Long-Term Debt, Maturity, Year Three $8.70M.
- 2018-12-31: Long-Term Debt, Maturity, Year Three $21.23M.
- 2017-12-31: Long-Term Debt, Maturity, Year Three $15.29M.
- 2016-12-31: Long-Term Debt, Maturity, Year Three $7.50M.
| Period end | Long-Term Debt, Maturity, Year Three |
|---|---|
| 2019-12-31 | $8.70M 20-F · filed 2020-04-30 |
| 2018-12-31 | $21.23M 40-F · filed 2019-03-13 |
| 2017-12-31 | $15.29M 20-F · filed 2018-04-30 |
| 2016-12-31 | $7.50M 40-F · filed 2017-03-29 |
| 2015-12-31 | $2.00M 40-F · filed 2016-03-29 |
| 2014-12-31 | $4.11M 40-F · filed 2015-03-27 |